ANDROID-F Drug Patent Profile
✉ Email this page to a colleague
When do Android-f patents expire, and what generic alternatives are available?
Android-f is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in ANDROID-F is fluoxymesterone. There are three drug master file entries for this compound. Additional details are available on the fluoxymesterone profile page.
Summary for ANDROID-F
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 10 |
Patent Applications: | 4,286 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ANDROID-F at DailyMed |
Recent Clinical Trials for ANDROID-F
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital of North Norway | Phase 4 |
St. Olavs Hospital | Phase 4 |
Oslo University Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ANDROID-F
US Patents and Regulatory Information for ANDROID-F
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | ANDROID-F | fluoxymesterone | TABLET;ORAL | 087196-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |